| publication name | Do we need to screen Egyptian voluntary blood donors for toxoplasmosis? |
|---|---|
| Authors | Nagwa Mostafa El-Sayed1*, Maha Mohamed Abdel-Wahab1, Shereen Magdy Kishik2, Naglaa Fathy Alhusseini3 |
| year | 2016 |
| keywords | Toxoplasma gondii Blood donors ELISA PCR |
| journal | Asian Pacific Journal of Tropical Disease |
| volume | 6 |
| issue | (4): |
| pages | 260-264 |
| publisher | elsevier |
| Local/International | International |
| Paper Link | Not Available |
| Full paper | download |
| Supplementary materials | Not Available |
Abstract
Objective: To determine the value of voluntary blood donors screening in diagnosing asymptomatic toxoplasmosis in an attempt to reduce the risk of this infection in Egyptian immunocompromised recipients. Methods: Serum samples from 300 healthy voluntary blood donors were analyzed for anti- Toxoplasma antibodies [immunoglobulin G (IgG) and immunoglobulin M (IgM)] using ELISA and detection of Toxoplasma gondii (T. gondii) parasitemia was done by real-time quantitative PCR (qrtPCR). Results: Frequency of T. gondii infection in 300 healthy blood donors was 101 (33.67%), 10 (3.33%), 18 (6.00%) by ELISA IgG, IgM and qrtPCR, respectively. It was found that 8 of 18 (44.4%) donor samples positive by qrtPCR contained IgM anti-T. gondii, conversely 8 of 10 (80%) IgM-positive samples were positive for T. gondii DNA. There was a highly significant increase in detection of recent Toxoplasma infection using PCR over IgM ELISA by 55.6%. At the same time, T. gondii parasitemia was detected in 11 of 101 (10.90%) donor samples positive by IgG ELISA and in 7 of 199 (3.50%) negative donor samples for anti-T. gondii IgG antibodies. On the other hand, the negative results obtained by both qrtPCR and ELISA in 192 (64%) subjects ruled out the infection in those donors. Conclusions: It might be appropriate to include the screening of blood and blood products for T. gondii in the pre-transfusion blood testing schedule in Egypt. Also, molecular screening should be carried out on the blood being transfused to immunocompromised patients.